Fetal lung maturation and the antenatal use of glucocorticoids to prevent the respiratory distress syndrome.
D000818:Animals; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000503:physiopathology; D005333:Fetus / Q000187:drug effects* / Q000502:physiology; D005938:Glucocorticoids / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D011247:Pregnancy; D011650:Pulmonary Alveoli / Q000187:drug effects* / Q000502:physiology; D011663:Pulmonary Surfactants / Q000502:physiology; D011817:Rabbits; D051381:Rats; D011965:Receptors, Glucocorticoid / Q000502:physiology; D012127:Respiratory Distress Syndrome, Newborn / Q000503:physiopathology / Q000517:prevention & control*
D005938:Glucocorticoids; D011663:Pulmonary Surfactants; D011965:Receptors, Glucocorticoid